This study describes the relationship between vasodilating effect. The results of this study lead to the hypothesis that through the pH nitroglycerin, isosorbide dinitrate, sodium modifications induced by these vasodilators by nitroprusside, and carbonic anhydrase I, as well the inhibition of carbonic anhydrase I, the as the involvement of this carbonic anhydrase I in isozyme may be involved in the regulation of vasodilation. 
D
in HCl production, while in the kidney it is involved in the maintenance of urinary pH, along with CA IV.
Isosorbide nitrates ( ISDN ) , nitroglycerine ( NG ) , and sodium nitroprusside ( SNP ) are substances with iscovered in 1932, carbonic anhydrase ( CA ) is a zinc-containing enzyme, which catalyzes the reversible reaction of CO 2 hydration, with production of H / and HCO 0 3 , vasodilating effects, known and successfully used in holding a central role in maintaining the acid-base equithe treatment of coronary disorders and arterial hylibrium in the organism. 1 Eight isozymes have been pertension. described so far, located in membranes, cytoplasm, mi-
The vasodilating action of these agents has been tochondria, etc. CA I is present both in erythrocytes proved to be initiated by nitric oxide ( NO ) producand in the vascular walls; its physiologic role is incomtion. 3 The differences between the vasodilating acpletely elucidated.
2 CA II is to be found both in erythrotions of these drugs consist in the ways in which NO cytes and in the cytoplasm; through its presence in the is released, ie, spontaneously in the case of SNP and parietal cells of the gastric mucosa, it has a central role by bioactivation and metabolic conversion in the case of organic nitrates.
4
Our studies have shown that vasoconstrictive sub-possessing vasodilating effects, such as adrenergic CO 2 solution. Assays were carried out spectrophotometrically at 400 nm, T Å 25ЊC, and pH Å 7.5. antagonists, prostaglandins ( PGs ) E 2 and I 2 , the inhibitors of the conversion enzyme, NO, and calcium Data were analyzed statistically by Student's t test. Glycerol trinitrate ( Trinitrosan ) was obtained from channel blockers, reduce the activity of this isozyme. 5 Considering the role of CA in maintaining the acid-Merck; isosorbide dinitrate ( Isoket ) from Schwarz Pharma AG ( Monheim, Germany ) ; sodium nitroprusside base equilibrium, we formulated the hypothesis that the pH modifications induced through the activation ( Nipride ) from Hoffman La Roche ( Switzerland ) ; and p -nitrophenol and HEPES buffer from Sigma ( Deisenor inhibition of CA I by these vasoconstrictive and vasodilating drugs might have a bearing on vascular hofen, Germany ) . tonus. RESULTS Studies carried out so far have shown that there is a relationship between intracellular pH and human These results are summarized in Table 1 and Figure 1 . and experimental hypertension 6 ; other studies have also demonstrated the involvement of intracellular Group I NG reduced total red cell CA activity by pH in the regulation of the tonus of smooth vascular 40% on the first day and by 51% after 2 days of treatmuscles. 7 ment. CA I activity decreased by 86% after the first In this paper we are studying the relationship be-day and was abolished ( 100% inhibition ) after the tween NG, ISDN, SNP, and CA I, an isozyme present second day of treatment. CA II activity was reduced both in erythrocytes and in the vascular endothelium. by 14% after the first day and by 25% after the second The modifications of CA I activity in red cells followed day of treatment. by us in this study will reflect the modifications of NG predominantly inhibited CA I, the inhibition bethe same isozyme in the vascular endothelium.
ing complete after 2 days of treatment. CA I inhibition was six times more powerful than CA II inhibition.
MATERIALS AND METHODS
Group II ISDN reduced total red cell CA activity by This study was carried out in vivo, in three experi-57% after 3 days of treatment. CA I activity was reduced mental groups. Group 1 ( N Å 59 ) consisted of patients by 90% after 2 days and by 100% after the third day of with coronary affections who were given glycerol treatment. CA II activity decreased by 30% after 3 days trinitrate ( Trinitrosan, Merck, Darmstadt, Germany ) of treatment in single intravenous doses of 5 mg / day on two conTreatment with ISDN progressively reduced CA acsecutive days. Red cell CA I and CA II activity was tivity in red blood cells. Inhibition of CA I was five determined every day from blood collected before and times more powerful than inhibition of CA II. Inhibition 30 min after the administration of glycerol trinitrate.
of CA I was progressive and became complete after 3 Group II ( N Å 55 ) consisted of coronary patients who days of treatment with ISDN. received ISDN in oral doses of 180 mg / day, administered at 12-h intervals ( 90 mg at a time ) , on 3 consecu-Group III SNP reduced total CA activity in the red tive days. Red cell CA I and CA II activity was deter-blood cells of rabbits; the decrease was progressive over mined every day, before and 2 h after drug adminis-the whole period of treatment. After 10 min of infusion, tration. Group III ( N Å 12 ) consisted of rabbits that inhibition of total CA reached 60%, CA I being comwere given 60 mg /min SNP by endovenous infusion pletely inhibited ( 100% ) , while CA II activity decreased over 10 min periods. The blood samples for the deter-by 48%; 30 min after discontinuing treatment, CA II mination of red cell CA I and CA II activity were was still inhibited by 27%, CA I by 30%. collected before treatment, after 5 and 10 min of infuAcute administration of SNP to rabbits induced comsion, and 30 min after discontinuing treatment.
plete inhibition of red cell CA I ( 100% ) after 10 min of The study was carried out according to interna-drug infusion. After discontinuing treatment with SNP, tional ethical standards.
CA I activity recovered sooner than CA II activity. Methyl nicotinate at a concentration of 5 1 10 04 mol / L was added to every blood sample in which DISCUSSION CA activity was determined. This was done in order to distinguish red cell CA I from CA II activity and The results obtained in this experiment show that NG, ISDN, and SNP induce strong and progressive inhibito obtain a separate value for each CA isozyme. 5 CA activity was determined by the stopped-flow tion of red cell CA I, an isozyme also present in vascular walls. The presence of the same isozyme, CA I, method.
8 Determinations were carried out with a rapid kinetics HI-TECH SF-51 MX apparatus (HI-TECH Scien-both in erythrocytes and in vascular walls leads to the assumption that the modifications of its activity occur tific Ltd., Salisbury, Wiltshire, England), the following reagents being used: 0. determined ) as an indicator for CA I activity changes that the NO released from NG, ISDN and SNP is responsible for the inhibition of CA I. in vascular walls.
The vasodilating mechanism of organic nitrates, Our previous studies have in fact shown that NO is an inhibitor of CA I by a direct mechanism of acsuch as NG and ISDN, described so far consists in generating NO by metabolic conversion mediated by tion, 5, 9 and that other vasodilators, substances such as PGE 2 , PGI 2 , 5,10 adrenergic receptor antagonists, nicfree thiols or by an enzymatic mechanism such as is achieved by glutathione-S-transferase or the P-450 cy-otinates, calcium channel blockers, 5 thiazidic diuretics, amiloride, and triamterene, 11 also inhibit CA I along tochrome. 4 Unlike the vasodilating effects of these organic nitrates, that of SNP is very powerful and rapid with vasodilation.
At the same time, vasoconstrictors, such as L-arginine and is achieved by spontaneous release of NO.
These results show that, along with the vasodilating analogs, 5,9 PGF 2a , thromboxane A 2 , leukotrienes B 4 and C 4 , catecholamines, angiotensin II, and vasopressin, effects of the three substances studied here, there also occurs a parallel inhibition of CA I. This inhibition is will activate CA I 5 ; the vasoconstrictive effects again occur in parallel with CA I activation. progressive over the duration of the treatment, CA I activity being completely inhibited after 2 or 3 days
Since the decrease of CA I activity accompanies the vasodilating effects of substances with various chemical of treatment, respectively, with NG and ISDN. After administration of SNP, whose effect sets in immedi-structures, it leads to the hypothesis that CA I is involved in the modulation of vascular tonus. This hyately, CA I activity is abolished within a 10 min infusion, but, after discontinuing treatment, the activity pothesis is supported by the increase of CA I activity induced by vasoconstrictive substances with various of the enzyme soon and gradually returns to initial values. Other studies performed here show that the chemical structures that activate the same isozyme in parallel with vasoconstriction. rapid return of CA I activity to initial values after discontinuing treatment with SNP is parallel to the Our hypothesis is strengthened by other studies that show that acetazolamide, known as a specific inhibitor return of arterial hypertension to its initial values after the same therapy. 5 Consequently, our results suggest of CA, 1 doubtlessly possesses cerebral vasodilating 
